

Publisher: Karger
E-ISSN: 1423-0313|56|2|71-79
ISSN: 0031-7012
Source: Pharmacology, Vol.56, Iss.2, 1998-01, pp. : 71-79
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Cytochrome P450 2. Pharmacogenetics
The Australian Journal of Hospital Pharmacy, Vol. 30, Iss. 3, 2000-06 ,pp. :


Expression of Cytochrome P450 2A5 in a C57BL/6J Mouse Model of Nonalcoholic Fatty Liver Disease
Pharmacology, Vol. 92, Iss. 1-2, 2013-07 ,pp. :



